{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:53:59Z","timestamp":1790916839696,"version":"4.1.0"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Diastolic dysfunction occurs when the left ventricle loses its ability to relax normally, impairing ventricular filling during diastole. This most commonly occurs as a pathological sequela of left ventricular hypertrophy and remodeling due to chronic hypertension and\/or age-related sclerotic changes of the aortic valve. This can subsequently deteriorate to diastolic heart failure or heart failure with preserved ejection fraction. There is a substantive interplay between atrial fibrillation and diastolic dysfunction, as atrial fibrillation can cause, exacerbate, or be a direct result of diastolic dysfunction and vice versa. In this review, we first independently define diastolic heart failure and atrial fibrillation while discussing the diagnostic guidelines, which encompass various modalities such as medical history, electrocardiography, echocardiography, and laboratory tests. We subsequently examine their interplay and pathophysiological links drawing on recent evidence in the literature. Finally, we discuss management approaches, including pharmacological interventions targeting rate and rhythm control, diuretics, and addressing comorbidities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/crd.0000000000000724","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T09:01:27Z","timestamp":1716454887000},"page":"508-512","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Diastolic Dysfunction and Atrial Fibrillation"],"prefix":"10.1097","volume":"34","author":[{"given":"Somar","family":"Hadid","sequence":"first","affiliation":[{"name":"School of Medicine, New York Medical College, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud El","family":"Hajj","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Montefiore St. Luke\u2019s Cornwall Hospital, Newburgh, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bana","family":"Hadid","sequence":"additional","affiliation":[{"name":"Department of Medicine, Columbia University Irving Medical Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoya","family":"Siddiqui","sequence":"additional","affiliation":[{"name":"School of Medicine, New York Medical College, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medicine, Westchester Medical Center, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Frishman","sequence":"additional","affiliation":[{"name":"School of Medicine, New York Medical College, Valhalla, NY"},{"name":"Department of Medicine, Westchester Medical Center, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilbert S.","family":"Aronow","sequence":"additional","affiliation":[{"name":"School of Medicine, New York Medical College, Valhalla, NY"},{"name":"Department of Medicine, Westchester Medical Center, Valhalla, NY"},{"name":"Department of Cardiology, Westchester Medical Center, Valhalla, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"key":"R1-20261002","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/CRD.0000000000000303","article-title":"Diastolic heart failure: a review of current and future treatment options.","volume":"29","author":"Goldstein","year":"2021","journal-title":"Cardiol Rev"},{"key":"R3-20261002","first-page":"222","article-title":"Diastolic heart failure: predictors of mortality.","volume":"18","author":"Sherazi","year":"2011","journal-title":"Cardiol J"},{"key":"R4-20261002","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cardfail.2023.07.006","article-title":"Heart failure epidemiology and outcomes statistics: a report of the heart failure society of America.","volume":"29","author":"Bozkurt","year":"2023","journal-title":"J Card Fail"},{"key":"R5-20261002","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1161\/01.CIR.0000140722.85490.EA","article-title":"Targeted therapy to prevent progression of calcific aortic stenosis.","volume":"110","author":"Rajamannan","year":"2004","journal-title":"Circulation"},{"key":"R6-20261002","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1161\/CIRCULATIONAHA.116.023997","article-title":"Medical treatment of aortic stenosis.","volume":"134","author":"Marquis-Gravel","year":"2016","journal-title":"Circulation"},{"key":"R7-20261002","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.tcm.2019.05.003","article-title":"Blood pressure and the new ACC\/AHA hypertension guidelines.","volume":"30","author":"Flack","year":"2020","journal-title":"Trends Cardiovasc Med"},{"key":"R11-20261002","doi-asserted-by":"crossref","first-page":"e236639","DOI":"10.1136\/bcr-2020-236639","article-title":"Rheumatic pericarditis: a rare cause of constrictive pericarditis.","volume":"14","author":"O\u2019Connor","year":"2021","journal-title":"BMJ Case Rep"},{"key":"R12-20261002","first-page":"2609","article-title":"Diastolic heart failure: challenges of diagnosis and treatment.","volume":"69","author":"Gutierrez","year":"2004","journal-title":"Am Fam Physician"},{"key":"R13-20261002","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines.","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R14-20261002","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"R15-20261002","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.","volume":"29","author":"Nagueh","year":"2016","journal-title":"J Am Soc Echocardiogr"},{"key":"R16-20261002","doi-asserted-by":"crossref","first-page":"12","DOI":"10.32481\/djph.2023.08.004","article-title":"Atrial fibrillation: a common cause of stroke.","volume":"9","author":"Tai","year":"2023","journal-title":"Dela J Public Health"},{"key":"R17-20261002","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"R18-20261002","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines.","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"R19-20261002","doi-asserted-by":"crossref","first-page":"e12528","DOI":"10.1111\/anec.12528","article-title":"Coarse fibrillatory waves in atrial fibrillation predict success of electrical cardioversion.","volume":"23","author":"Zhao","year":"2018","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"R21-20261002","first-page":"363","article-title":"Hyperthyroidism: diagnosis and treatment.","volume":"93","author":"Kravets","year":"2016","journal-title":"Am Fam Physician"},{"key":"R22-20261002","first-page":"305","article-title":"Atrial fibrillation and hyperthyroidism.","volume":"5","author":"N","year":"2005","journal-title":"Indian Pacing Electrophysiol J"},{"key":"R23-20261002","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1093\/eurheartj\/ehad592","article-title":"Prevalence and incidence of diastolic dysfunction in atrial fibrillation: clinical implications.","volume":"44","author":"Naser","year":"2023","journal-title":"Eur Heart J"},{"key":"R24-20261002","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1161\/01.CIR.93.6.1262","article-title":"Management of patients with atrial fibrillation. a statement for healthcare professionals. from the subcommittee on electrocardiography and electrophysiology, American Heart Association.","volume":"93","author":"Prystowsky","year":"1996","journal-title":"Circulation"},{"key":"R25-20261002","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1358\/dot.2008.44.7.1221662","article-title":"Diastolic dysfunction: a link between hypertension and heart failure.","volume":"44","author":"Lalande","year":"2008","journal-title":"Drugs Today (Barc)"},{"key":"R26-20261002","first-page":"810","article-title":"Left atrial fibrosis: role in atrial fibrillation pathophysiology and treatment outcomes.","volume":"5","author":"Spragg","year":"2013","journal-title":"J Atr Fibrillation"},{"key":"R27-20261002","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.1038\/s41598-018-24875-1","article-title":"Association between atrial fibrillation, atrial enlargement, and left ventricular geometric remodeling.","volume":"8","author":"Seko","year":"2018","journal-title":"Sci Rep"},{"key":"R28-20261002","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/qjmed\/hcy088","article-title":"Clinical significance of atrial kick.","volume":"111","author":"Namana","year":"2018","journal-title":"QJM"},{"key":"R29-20261002","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1161\/CIRCULATIONAHA.108.821306","article-title":"Atrial fibrillation and heart failure: treatment considerations for a dual epidemic.","volume":"119","author":"Anter","year":"2009","journal-title":"Circulation"},{"key":"R30-20261002","first-page":"3250","article-title":"Atrial fibrillation in heart failure: what should we do?","volume":"36","author":"Kotecha","year":"2015","journal-title":"Eur Heart J"},{"key":"R31-20261002","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/heartjnl-2015-307438","article-title":"Association between diastolic dysfunction and future atrial fibrillation in the Tromso Study from 1994 to 2010.","volume":"101","author":"Tiwari","year":"2015","journal-title":"Heart"},{"key":"R32-20261002","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/1753944712464101","article-title":"Burden of comorbidities among patients with atrial fibrillation.","volume":"7","author":"LaMori","year":"2013","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"R33-20261002","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jacc.2015.06.1314","article-title":"Incidence of atrial fibrillation and relationship with cardiovascular events, heart failure, and mortality: a community-based study from the Netherlands.","volume":"66","author":"Vermond","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"R34-20261002","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.2023.2020","article-title":"Heart failure with preserved ejection fraction: a review.","volume":"329","author":"Redfield","year":"2023","journal-title":"JAMA"},{"key":"R35-20261002","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pcad.2005.06.005","article-title":"Asymptomatic atrial fibrillation.","volume":"48","author":"Rho","year":"2005","journal-title":"Prog Cardiovasc Dis"},{"key":"R36-20261002","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.nurpra.2018.08.015","article-title":"Atrial fibrillation symptom perception.","volume":"15","author":"Streur","year":"2019","journal-title":"J Nurse Pract"},{"key":"R37-20261002","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jcmg.2018.10.039","article-title":"Asymptomatic left ventricular diastolic dysfunction: predicting progression to symptomatic heart failure.","volume":"13","author":"Kosmala","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"R39-20261002","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines.","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"R40-20261002","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jcmg.2020.08.020","article-title":"Softening the stiff heart: SGLT2 inhibition and diastolic function.","volume":"14","author":"Connelly","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"R41-20261002","first-page":"143","article-title":"Association of atrial fibrillation with diabetes mellitus, high risk comorbidities.","volume":"17","author":"Ph","year":"2022","journal-title":"Maedica (Bucur)"},{"key":"R42-20261002","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1161\/CIRCHEARTFAILURE.113.001229","article-title":"Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction.","volume":"7","author":"Adamson","year":"2014","journal-title":"Circ Heart Fail"},{"key":"R43-20261002","first-page":"29","article-title":"Infiltrative cardiomyopathies.","volume":"9","author":"Bejar","year":"2015","journal-title":"Clin Med Insights Cardiol"},{"key":"R44-20261002","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1001\/jama.298.11.1312","article-title":"Prescribing amiodarone: an evidence-based review of clinical indications.","volume":"298","author":"Vassallo","year":"2007","journal-title":"JAMA"},{"key":"R45-20261002","doi-asserted-by":"crossref","first-page":"82G","DOI":"10.1016\/S0002-9149(97)00717-0","article-title":"Proarrhythmia with class III antiarrhythmic drugs: types, risks, and management.","volume":"80","author":"Hohnloser","year":"1997","journal-title":"Am J Cardiol"},{"key":"R46-20261002","first-page":"2189","article-title":"Amiodarone: guidelines for use and monitoring.","volume":"68","author":"Siddoway","year":"2003","journal-title":"Am Fam Physician"},{"key":"R47-20261002","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1161\/CIRCULATIONAHA.123.066989","article-title":"Antiarrhythmic drug therapy: where do we go from here?","volume":"149","author":"Kowey","year":"2024","journal-title":"Circulation"},{"key":"R48-20261002","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa1001337","article-title":"Lenient versus strict rate control in patients with atrial fibrillation.","volume":"362","author":"Van Gelder","year":"2010","journal-title":"N Engl J Med"},{"key":"R49-20261002","first-page":"582","article-title":"Heart failure with preserved ejection fraction: diagnosis and management.","volume":"96","author":"Gazewood","year":"2017","journal-title":"Am Fam Physician"},{"key":"R50-20261002","first-page":"1045","article-title":"Guideline for the management of heart failure caused by systolic dysfunction: part II. Treatment.","volume":"64","author":"Chavey","year":"2001","journal-title":"Am Fam Physician"},{"key":"R51-20261002","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1751-7176.2011.00513.x","article-title":"Calcium channel blockers.","volume":"13","author":"Elliott","year":"2011","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"R53-20261002","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the heart rhythm society in collaboration with the society of thoracic surgeons.","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"R54-20261002","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1503\/cmaj.150867","article-title":"Bridging anticoagulation for interruption of warfarin in a patient with atrial fibrillation.","volume":"188","author":"Tseng","year":"2016","journal-title":"CMAJ"},{"key":"R55-20261002","doi-asserted-by":"crossref","first-page":"603.e1","DOI":"10.1016\/j.amjmed.2011.09.030","article-title":"Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation.","volume":"125","author":"Mason","year":"2012","journal-title":"Am J Med"},{"key":"R56-20261002","doi-asserted-by":"crossref","first-page":"235","DOI":"10.14797\/mdcj-11-4-235","article-title":"Mineralocorticoid receptor antagonists for treatment of hypertension and heart failure.","volume":"11","author":"Sica","year":"2015","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"R57-20261002","doi-asserted-by":"crossref","first-page":"73","DOI":"10.36628\/ijhf.2020.0002","article-title":"Angiotensin Receptor-Neprilysin Inhibition (ARNI) in heart failure.","volume":"2","author":"Greenberg","year":"2020","journal-title":"Int J Heart Fail"},{"key":"R58-20261002","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11906-023-01281-1","article-title":"Blood pressure effects of SGLT2 inhibitors: mechanisms and clinical evidence in different populations.","volume":"25","author":"Beal","year":"2023","journal-title":"Curr Hypertens Rep"},{"key":"R59-20261002","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jacbts.2022.05.010","article-title":"Neprilysin inhibitors in heart failure: the science, mechanism of action, clinical studies, and unanswered questions.","volume":"8","author":"Bozkurt","year":"2023","journal-title":"JACC Basic Transl Sci"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CRD.0000000000000724","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:00:56Z","timestamp":1790913656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CRD.0000000000000724"}},"subtitle":["Recognition, Interplay, and Management"],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000724","relation":{},"ISSN":["1061-5377","1538-4683"],"issn-type":[{"value":"1061-5377","type":"print"},{"value":"1538-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,23]]}}}